RR
Ramamohan Rao Davuluri
About Ramamohan Rao Davuluri
Data last updated:
Ramamohan Rao Davuluri is a Whole-Time Director at Neuland Laboratories Ltd (since 1984) and Director at Pattancheru Enviro-Tech Limited (since 1996). The companies operate in Pharma and Environment. The 2 current companies with reported revenue have a combined latest revenue of ₹1,517 Cr; the largest is Neuland Laboratories Ltd at ₹1,497 Cr (FY 2025). Earlier, Ramamohan Rao Davuluri was a Director at Asvi Therapeutics Private Limited (from 2020) and Director at Neuland Health Sciences Private Limited (from 2012) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 07 Jan 1984 | 1984 | ₹1,497 Cr (FY 2025) | Active | |
| Director | 06 Aug 1996 | 1989 | ₹19.79 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2020 | 2020 | Strike Off | ||
| Director | 16 Apr 2012 | 1993 | ₹580 Cr (FY 2017) | Amalgamated | |
| Director | 23 Apr 2012 | 2012 | ₹61.52 Cr (FY 2017) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramamohan Rao Davuluri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhijit Ajay Majumdar | Neuland Laboratories Ltd | Cfo | |
| Homi Rustam Khusrokhan | 00005085 | Neuland Laboratories Ltd | Director |
| Mauricio Futran | 11699767 | Neuland Laboratories Ltd | Additional Director |
| Pallavi Joshi Bakhru | 01526618 | Neuland Laboratories Ltd | Director |
| Prasad Raghava Menon | 00005078 | Neuland Laboratories Ltd | Director |
| Ravi Shankar Gopinath | 00803847 | Neuland Laboratories Ltd | Director |
| Saharsh Rao Davuluri | 02753145 | Neuland Laboratories Ltd | Whole-Time Director |
| Sarada Bhamidipati | Neuland Laboratories Ltd | Company Secretary | |
| Sucheth Rao Davuluri | 00108880 | Neuland Laboratories Ltd , Pattancheru Enviro-Tech Limited | Whole-Time Director |
| Sugata Sircar | 01119161 | Neuland Laboratories Ltd | Director |
| Nityananda Reddy Kambam | 01284195 | Pattancheru Enviro-Tech Limited | Director |
| Ranga Raju Kanumuri | 00043186 | Pattancheru Enviro-Tech Limited | Director |
| Sadhu Sundar Mallela | 02225017 | Pattancheru Enviro-Tech Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramamohan Rao Davuluri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramamohan Rao Davuluri
Ramamohan Rao Davuluri currently holds 2 directorships: Neuland Laboratories Ltd (Whole-Time Director, since 07 Jan 1984, revenue ₹1,497 Cr (FY 2025)); Pattancheru Enviro-Tech Limited (Director, since 06 Aug 1996, revenue ₹19.79 Cr (FY 2025)).
Ramamohan Rao Davuluri was first appointed on 07 Jan 1984 as Whole-Time Director at Neuland Laboratories Ltd. The most recent appointment on record is 01 Dec 2020 at Asvi Therapeutics Private Limited.
The 2 current companies of Ramamohan Rao Davuluri that report revenue have a combined latest revenue of ₹1,517 Cr: Neuland Laboratories Ltd ₹1,497 Cr (FY 2025); Pattancheru Enviro-Tech Limited ₹19.79 Cr (FY 2025).
Ramamohan Rao Davuluri held 3 earlier board appointments: Asvi Therapeutics Private Limited (Director, from 01 Dec 2020); Neuland Health Sciences Private Limited (Director, from 16 Apr 2012); Neuland Pharma Research Private Limited (Director, from 23 Apr 2012).
The current boards of Ramamohan Rao Davuluri's companies include Abhijit Ajay Majumdar (Neuland Laboratories Ltd), Homi Rustam Khusrokhan (Neuland Laboratories Ltd), Mauricio Futran (Neuland Laboratories Ltd), Pallavi Joshi Bakhru (Neuland Laboratories Ltd), Prasad Raghava Menon (Neuland Laboratories Ltd), Ravi Shankar Gopinath (Neuland Laboratories Ltd), among others.